计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175765-100μg |
100μg |
现货 ![]() |
| |
| Ab175765-1mg |
1mg |
现货 ![]() |
| |
| Ab175765-5mg |
5mg |
现货 ![]() |
| |
| Ab175765-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Fremanezumab (anti-CALCA), 降钙素基因相关肽拮抗剂的拮抗剂 |
|---|---|
| 别名 | 瑞玛奈珠单抗 | Fremanezumab(抗 CALCA) |
| 英文别名 | Calcitonin/calcitonin related polypeptide alpha antibody | Alpha type CGRP antibody | Beta type CGRP antibody | CALC1 antibody | CALC2 antibody | CALCA antibody | CALCB antibody | Calcitonin 1 antibody | Calcitonin 2 antibody | Calcitonin gene related pep |
| 规格或纯度 | 无载体, 重组, ExactAb™, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | CALCA |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 作用类型 | 拮抗剂 |
| 作用机制 | 降钙素基因相关肽拮抗剂的拮抗剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG2SA |
| 轻链亚型 | kappa |
| SDS-PAGE | 27.2 kDa (Light Chain) & 49.8 kDa (Heavy Chain), under reducing conditions; 160.5 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% (SDS-PAGE&SEC) |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1655501-53-3 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Fremanezumab (anti-CALCA) (Ab175765) - ELISA
Immobilized hu-CALCA-KLH at 2 μg/mL can bind Fremanezumab (anti-CALCA) (Ab175765) with the EC₅₀ of 6.76 ng/mL.
Fremanezumab (anti-CALCA) (Ab175765) - SEC
The purity of Fremanezumab (anti-CALCA) (Ab175765) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab175765 | |
| 分析证书 | Ab175765 | |
| 分析证书 | Ab175765 | |
| 分析证书 | Ab175765 | |
| 分析证书 | Ab175765 | |
| 分析证书 | Ab175765 |
¥431.92
¥271.92
¥339.90
¥551.92
| 1. Recober A, Russo AF. (2007) Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment.. IDrugs, 10 (8): (566-74). [PMID:17665333] |
| 2. Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R. (2016) Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.. Eur J Med Chem, 109 (216-37). [PMID:26774927] |
| 3. Xu R, Wang K, Rizzi JP, Huang H, Grina JA, Schlachter ST, Wang B, Wehn PM, Yang H, Dixon DD et al.. (2019) 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma.. J Med Chem, 62 (15): (6876-6893). [PMID:31282155] |
| 4. Miranda LP, Holder JR, Shi L, Bennett B, Aral J, Gegg CV, Wright M, Walker K, Doellgast G, Rogers R, Li H, Valladares V, Salyers K, Johnson E, Wild K.. (2008) Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor.. J Med Chem, 51 (24): (7889-7897). [PMID:19053766] [10.1021/jm8009298] |
| 5. Civiello RL, Han X, Beno BR, Chaturvedula PV, Herbst JJ, Xu C, Conway CM, Macor JE, Dubowchik GM.. (2016) Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines.. Bioorg Med Chem Lett, 26 (4): (1229-1232). [PMID:26832218] [10.1016/j.bmcl.2016.01.026] |
| 6. Waszkielewicz AM, Gunia-Krzyżak A, Powroźnik B, Słoczyńska K, Pękala E, Walczak M, Bednarski M, Żesławska E, Nitek W, Marona H.. (2016) Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.. Bioorg Med Chem, 24 (8): (1793-1810). [PMID:26988801] [10.1016/j.bmc.2016.03.006] |
| 7. Kitamura, K K and 5 more authors.. (1992) Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma.. Biochemical and biophysical research communications, (29): [PMID:1318039] |
| 8. Breeze, A L AL, Harvey, T S TS, Bazzo, R R and Campbell, I D ID.. (1991) Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics.. Biochemistry, (15): [PMID:1988044] |
| 9. Hubbard, J A JA and 5 more authors.. (1991) Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin.. The Biochemical journal, (1): [PMID:2039456] |
| 10. Edbrooke, M R MR and 6 more authors.. (1985) Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma.. The EMBO journal, [PMID:2408883] |
| 11. Broad, P M PM, Symes, A J AJ, Thakker, R V RV and Craig, R K RK.. (1989) Structure and methylation of the human calcitonin/alpha-CGRP gene.. Nucleic acids research, (12): [PMID:2571128] |
| 12. Craig, R K RK and 7 more authors.. (1986) Expression and function of the human calcitonin/alpha-CGRP gene in health and disease.. Biochemical Society symposium, [PMID:3034287] |
| 13. Petermann, J B JB, Born, W W, Chang, J Y JY and Fischer, J A JA.. (1987) Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord.. The Journal of biological chemistry, (15): [PMID:3492492] |
| 14. Jonas, V V and 7 more authors.. (1985) Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:3872459] |
| 15. Nelkin, B D BD and 5 more authors.. (1984) Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide.. Biochemical and biophysical research communications, (17): [PMID:6148938] |
| 16. Morris, H R HR and 5 more authors.. (1984) Isolation and characterization of human calcitonin gene-related peptide.. Nature, [PMID:6609312] |
| 17. Steenbergh, P H PH and 5 more authors.. (1984) Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma.. The Journal of clinical endocrinology and metabolism, [PMID:6610687] |
| 18. Dodick, David W DW and 13 more authors.. (2014) Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.. The Lancet. Neurology, [PMID:25297013] |
| 19. Monteith, David D and 8 more authors.. (2017) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.. Frontiers in pharmacology, [PMID:29089894] |